We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Ergomed Plc | ERGO | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1,346.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1,346.00 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 29/9/2023 10:56 by piedro Amanti sent a LOI in favour of the proposed Scheme... in respect of 1,114,609 Ergomed Shares, representing approximately 2.2 per cent. of the issued share capital ... BUT sold all, As at the date of this announcement, Amati Global Investors no longer holds any Ergomed Shares and, accordingly, the letter of intent from Amati Global Investors has ceased to apply and has been withdrawn. Therefore, Bidco has received irrevocable undertakings or letters of intent in respect of a total of 9,129,297 Ergomed Shares representing approximately 17.9 per cent. of the existing issued share capital of Ergomed to vote in favour of the Scheme at the Court Meeting and the Resolution(s) to be proposed at the General Meeting. WHAT does that signify? From the Offer Document: Miroslav Reljanović has irrevocably undertaken to vote in favour of the Scheme in respect of his own Ergomed Shares (representing approximately 17.9 per cent. of the issued ordinary share capital of Ergomed). LOOKS like I must read through all those daily notifications to understand WHAT is GOING ON !! |
Posted at 28/10/2021 12:00 by piedro Richard Barfield presented at the Proactive One2One virtual investor forum |
Posted at 25/7/2021 16:50 by sharesoc Last chance to register for our webinar with Ergomed on the 29th July. Richard Barfield (CFO) will be presenting the latest updates which may be of interest to current shareholders and potential investors. |
Posted at 12/7/2021 13:47 by sharesoc We are hosting a webinar with Ergomed plc on the 29th July which may be of interest to current shareholders and potential investors: |
Posted at 07/4/2021 11:33 by adorling Obviously someone or some fund is selling as we have retraced 16% now in 4 weeks? Recent Results and investor presentations were robust? |
Posted at 27/3/2021 18:11 by maddox Richard Barfield, CFO Ergomed on Shares Magazine - Shares Investor EveningExcellent presentation. Very strong results – two acquisitions, strong growth, US market presence is paying-off, strong cash generation based on high cash conversion (98%) and a huge order book (up 55% under-pinning future growth). ERGO has led the development of digitisation of service delivery which has of course been thrust forward with Covid-19. It’s likely that ERGO will finance further acquisitions funded out of its own resources. In this growing market with high quality returns – this is good use of its cash. So forward p/e of 40 is not cheap but fair value in consideration of a fast organic growth and internally funded acquired growth. Regards Maddox |
Posted at 13/12/2020 10:25 by bramble13 No , this is just some traders taking a bit of profit after a big price increase. It isn't a bad thing,it will Bring in new investors .The price will soon resume the upward trend. It is also a wonderful opportunity to increase your holding.Have faith my friends. |
Posted at 11/12/2020 10:22 by bramble13 Don't think for one moment you have missed out on this company, this is just the beginning of a long financial gain for investors. Last year was a transformational year, the chairman said so,and he knows best.He also said this will be a year Matterialy ahead of expectations.We can look forward to many years of a good dividend yield.This is going to a high growth company for long term holdersDon't be frightened of the high share price. |
Posted at 07/12/2020 08:15 by grabster Thanks Ayl30"Midas verdict: At £9.30, Ergomed shares have done well this year, benefiting from increased investor interest in almost all healthcare stocks. However, the company is profitable, its balance sheet is robust and the shares should continue to rise as Reljanovic and Barfield roll out their strategy. Buy." (clickable version of your link: ) |
Posted at 10/10/2020 08:13 by tongosti I am 100% with what you describe on the fundamental front so yes, ERGO looks set to be on the path of something special. Revenue / EPS / margin growth are some of the best in the business. No doubt about that. The reason that I am not in - at this particular point in time - is purely technical in nature. If you maybe aware of the likes of incredibly successful high growth company investors like William O'Neil or Mark Minervini - there's the answer to your question. Broadly speaking, a company may go up 500% from A to B. As I try very hard to avoid inevitable volatility in between those points (to me an account drawdown of about 10-12% max is a very, very serious concern) I am content at trying trading in and out several times during that A to B journey. Is it a precise science? Of course not - which inevitably mean that I will also miss good short term trading opps here and there. Still worth it though (for me) as that's the price I am willing to pay for managing risk. As a matter of fact, I am obsessed with controlling risk hence my preferred way of playing the game. Again happy for you and all holders - I will certainly join you in the journey multiple times in what is a phenomenal growth story. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
